Prime Highlights
- Tandem Health grew its customer base from just over 1,000 to 5,000 healthcare providers in under a year, now operating across 12 European countries.
- CEO Lukas Saari said large frontier labs are demand catalysts for vertical AI products rather than a competitive threat to specialised startups.
Key Facts
- Tandem Health is a Swedish startup that offers an AI-powered medical scribe tool designed to reduce documentation workload for clinicians.
- The company’s largest market is the UK, where adoption of AI tools in clinical settings has grown steadily alongside broader European healthtech investment.
Background
Medical transcriptionist company Tandem Health of Sweden has seen exponential growth in 2025, with its services now being utilised in 12 different countries in Europe. Tandem Health has been able to expand its customer base from 1,000 to 5,000 health care facilities since mid-last year.
CEO Lukas Saari said the company grew more than tenfold in 2025. The startup offers an AI-powered medical scribe tool built for clinicians, helping reduce documentation workload during patient consultations.
The growth comes as interest in AI tools for healthcare has risen across Europe. Saari and the CEO of another Swedish AI startup publicly pushed back against the view that large frontier labs such as OpenAI and Anthropic pose a threat to specialised AI businesses. Both argued that wider consumer interest in chatbots has actually driven demand for vertical, domain-specific products like theirs.
The debate reflects a wider conversation in the sector. Large model providers have begun launching domain-focused features, with OpenAI introducing a health-focused product in the United States and Anthropic releasing a legal plug-in. For founders of vertical AI startups, this is an indication of a signal that will generate enterprise interest rather than competition.
The expansion of Tandem puts it in a fast-growing group of European healthtech startups developing their product-market fit on a large scale. It is stressed that there are multiple differences between vertical AI and frontier AI solutions in such aspects as EHR compatibility, data governance, and regulatory compliance, among others.
The company has disclosed no financial information yet, but its provider success shows strong signs of growth in the European clinical AI sector.
